25 February 2018
News and Views
Links and Services
November's issue of the Clinical Gastroenterology & Hepatology reports that central adiposity is associated with an increased risk of esophageal inflammation, metaplasia, and adenocarcinoma.
Central adiposity has been implicated as a risk factor for Barrett's esophagus and esophageal ade
Email this page to a colleague
GastroHep.com is a Blackwell Publishing registered trademark
© 2018 Wiley-Blackwell and GastroHep.com and contributors